Cetuximab (Erbitux®) for the treatment of metastatic colorectal cancer

Zorginstituut Nederland has carried out a re-assessment of the medicinal product cetuximab (Erbitux®), whereby they came to the conclusion that, for the assessed indication, cetuximab a therapeutic added value has in comparison with FOLFOX alone.